Invention relates to a method of identifying small molecule inhibitors for the HIV TAT using a high throughput screening (HTS) assay, which will aid in the development of new class of HIV drugs. It relates to a TAT-inducible GFP anti RFP shRNA vector, vector combinations, recombinant cell having vectors comprising nucleotide sequence sets. The technology can effectively distinguish between a genuine anti-viral inhibitor and a cytotoxic molecule and thus , decreases the number of false hits.

For more details about technology:: Click here

Technology relates to a Three-Dimensional Stereomicroscope with a variable inter-objective distance to provide an increased field and depth of vision. Using the proposed technology problem of restricted image formation is solved, and the proposed device can be used for industrial, laboratory and medical operation in a easy and safe way.

For more details about technology:: Click here

Technology relates to a microbial formulation for promoting plant growth comprises a mixture of beneficial microbial isolates for customized solution of soil health related problem. The microbial formulation provides protection against plant pathogens, lower the need for nitrogen containing fertilizers and soluble minerals, and make plant valuable nutrients available, and thus reduce or eliminate the need for chemical pesticides and chemical fertilizers.

Patent Application Number: WO2010109436

For more details about technology: Click Here

Technology is relevant to manufacturers of surgical medical equipment, specifically medical imaging devices. System uses innovative three-dimensional C-arm X-ray (fluoroscope) imaging to improve the accuracy of needle insertion guidance for increasing the success of kidney stone removal (percutaneous nephrolithotomy) as well as other needle insertion procedures.

Patent Application Number : WO2010097697

For more details about technology: Click Here

Invention relates to an extended release formulation of a broad spectrum macrolide antibiotic such as clarithromycin comprising a unique blend of polymer matrix using two different grades hydroxypropylmethyl cellulose, sodium carbonate and other excepients in an optimized ratio to achieve an extended or delayed drug release profile up to 12 hours without any chemical interaction between drug and excepients.

Patent Application Number: 552/KOL/2010

For more details about technology:Click here

Invention relates to a whey treatment in dairy industry collecting the whey as wastewater from cheese and/or paneer production section, performing chemical pre-treatment step using a combinations of chemical coagulants and adsorbents, passing through an integrated membrane cassette for whey protein concentration and recovery.

Patent Application Number: 1428/KOL/2011

For more details about technology:  Click here